Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5 Fluorouracil, and Leucovorin Versus Oxaliplatin, 5 Fluorouracil, Leucovorin, and Bevacizumab for Patients …
Oncologist(2019)
Abstract
BackgroundThe addition of bevacizumab to chemotherapy improved outcomes for patients with metastatic colon cancer. E5204 was designed to test whether the addition of bevacizumab to mFOLFOX6, following neoadjuvant chemoradiation and definitive surgery, could improve overall survival (OS) in patients with stage II/III adenocarcinoma of the rectum.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined